CRP and periodontitis: Hasturk et al. demonstrated that topical application of RvE1 (4 μg/site, three times per week for six weeks) reduced systemic biomarkers of inflammation [IL-1β and C-Reactive Protein (CRP)] and restored 95% of lost bone tissue, along with reported soft tissue regeneration, in a rabbit model of periodontitis [77].